Early Detection Is Key
Nucleix (nucleix.com) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 59th percentile of 20180 Healthcare brands.
Nucleix is an Israeli diagnostics company founded in 2008 and headquartered in Rehovot, Israel. It develops proprietary epigenetic-based diagnostic tests, including Bladder EpiCheck and Lung EpiCheck, designed to detect cancer earlier than conventional methods. The company's mission centers on improving patient outcomes through early, accurate cancer detection, serving oncologists, healthcare providers, diagnostic laboratories, and patients at risk of or being monitored for cancer.
| Brand Name | Nucleix |
|---|---|
| Domain | nucleix.com |
| Industry | Healthcare |
| Founded | 2008 |
| Headquarters | Rehovot |
| Main Competitors | Epigenomics AG, Exact Sciences (84/100), Guardant Health (87/100), Pacific Edge (54/100), Biodesix, Abbott (UroVysion) (91/100) |
Moz Domain Authority 38/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Nucleix develops advanced diagnostic tests aimed at detecting cancer earlier, when treatment can be most effective for patients." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, YouTube, GitHub; no detected presence on LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Nucleix?", Claude could identify the brand as of October 2026. Nucleix is an Israeli biotechnology company that develops epigenetic diagnostic tests based on DNA methylation patterns, with its main product being Bladder EpiCheck, a urine-based test used to detect and monitor bladder cancer recurrence. Best known for Bladder EpiCheck, a DNA methylation based urine test for bladder cancer recurrence monitoring.
When asked "Best brands similar to Nucleix?", Claude would recommend Nucleix as of October 2026. It's a notable player in liquid biopsy and epigenetic cancer diagnostics, so I'd mention it if someone asked about companies innovating in non-invasive cancer detection.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Nucleix's main competitors in Healthcare: Exact Sciences (84/100), Guardant Health (87/100), Pacific Edge (54/100), Abbott (UroVysion) (91/100).
Sources: Brand Analyzer scan
Nucleix offers epigenetic diagnostic tests including Bladder EpiCheck and Lung EpiCheck, designed to detect cancer earlier and more accurately using epigenetic biomarkers.
Sources: Nucleix official site
Nucleix is an Israeli healthcare company founded in 2008 and headquartered in Rehovot, Israel, specializing in the development of advanced diagnostic tests for cancer detection.
Sources: Nucleix official site
Nucleix has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 22, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Nucleix official site
Nucleix was founded in 2008. Nucleix operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Nucleix is headquartered in Rehovot. Nucleix operates in the Healthcare category.
Sources: Wikidata
Nucleix develops epigenetic diagnostic technologies aimed at detecting cancer earlier, when treatment can be most effective. Its tests, such as Bladder EpiCheck and Lung EpiCheck, analyze epigenetic markers to identify cancer with greater accuracy than some traditional diagnostic methods.
Sources: Nucleix official site
Nucleix scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Nucleix official site
Nucleix is known for its proprietary epigenetic diagnostic tests, particularly Bladder EpiCheck and Lung EpiCheck, which are used to support earlier and more accurate detection of bladder and lung cancers.
Sources: Nucleix official site
Nucleix can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Nucleix official site
Nucleix's diagnostic tests are used by oncologists, healthcare providers, and diagnostic laboratories, as well as patients who are at risk of or being monitored for cancer.
Sources: Nucleix official site
Nucleix scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Nucleix has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 38/100 and thin schema.org structured data. In a live check, Claude could already identify Nucleix from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Nucleix: Ntracts (77/100), NTBHA (77/100), Nucleus Global (77/100), NUK (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.